Fused heteroaromatic pyrrolidinones

PK201001080A0Undetermined Publication Date: 2011-01-08TAKEDA PHARMA CO LTD
0 Cites 0 Cited by

Patent Information

Application Number
PK201001080
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2010-12-22
Publication Date
2011-01-08
Patent Text Reader

Abstract

Disclosed is a compound of Formula 1, wherein G, L1, L2, R1, R2, R3, and R4 are as defined in the specification. This disclosure also relates to material and method for preparing compound of Formula 1 and pharmaceutical composition containing it for treating disorders, diseases, and conditions involving the immune system and inflammation, including rheumatoid arthritis, hematological malignancies, epithelial cancers (i.e., carcinomas), and other disorders, diseases, and conditions for which inhibition of SYK is indicated.
Need to check novelty before this filing date? Find Prior Art